MHAT for women's health - Nadezhda, OOD

Sofia 1330

0 studies enrolling now · 7 studies all time

What they study most

Advanced Breast Cancer, Breast Cancer, Breast Cancer Female, Breast Neoplasm, Carcinoma, Ductal, Breast, Endometriosis, First Line Non-Small Cell Lung Cancer, Metastatic Breast Cancer, PD-L1-positive, Locally Advanced (Unresectable Stage IIIB/C) or Metastatic NSCLC, Solid Tumors, Stage IV Breast Cancer, Triple-Negative Breast Cancer

Studies at this site

• Trial to Evaluate Acasunlimab and Pembrolizumab Combination Superiority Over Standard of Care Docetaxel in Non-Small Cell Lung Cancer (ABBIL1TY NSCLC-06) — Running, not enrolling
• Avelumab Program Rollover Study — Running, not enrolling
• A Study to Investigate Efficacy and Safety of OG-6219 BID in 3 Dose Levels Compared With Placebo in Participants Aged 18 to 49 With Moderate to Severe Endometriosis-related Pain — Completed
• Avelumab in First-line NSCLC (JAVELIN Lung 100) — Completed
• Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids (ASTEROID 3) — Stopped early
• G1T48, an Oral SERD, Alone and in Combination With Palbociclib in ER-Positive, HER2-Negative Advanced Breast Cancer — Completed
• Trilaciclib (G1T28), a CDK 4/6 Inhibitor, in Combination With Gemcitabine and Carboplatin in Metastatic Triple Negative Breast Cancer (mTNBC) — Stopped early